According to a new report, 83% of life sciences CEOs see the Internet of Medical Things (IoMT) as the most important capability to grow their businesses. IoMT devices are rated as a higher priority than artificial intelligence in accelerating research and development. According to respondents, these technologies have the potential to improve operational efficiency in the healthcare sector. Globally, increased adoption of IoMT in healthcare has improved efficiency, quality of patient care and generated substantial economic value[3]. The COVID-19 pandemic has accelerated the adoption of IoMT devices, especially wearable medical devices that enable real-time health monitoring and advanced remote healthcare[3]. The report thus confirms that IoMT technologies are a key factor in future development in the field of life sciences and healthcare.